New Research Paves Way To Safer Treatments for Arthritis
|Appsread focuses in building an exclusive online community for Indian Pharma Industry professionals which includes Doctors, Research Associates, Students, Pharmacist, Advance Scanning Labs, Lab Technicians, Pharma manufacturers, Job Recruitment’s, Events, News Report, Pharma Medical Representatives.
According to technical committee of appsread the latest research from Imperial College London could pave the way to safer treatments for arthritis. By these latest findings one could avoid risk of heart attack or stroke associated with several arthritis drugs. The survey from appsread core committee suggests that drugs such as Vioxx, diclofenac, ibuprofen and Celebrex profusely operate by blocking an enzyme known as COX-2, whose presence in blood vessels held responsible for these side effects.
The latest medical research which was carried out on mice has proven that COX-2 is largely absent from the major blood vessels and found in the brain, gut, kidney and thymus gland in the chest. By this research one can easily find that where in the body the drug is acting, so now it is possible to develop safer and focused drugs for patients with arthritis as well as cancer. This medical research was conducted due to Arthritis drugs fatal effects and long term association with potentially fatal cardiovascular side-effects in patients.
According to media sources of appsread the anti-inflammatory Vioxx was withdrawn from the market in 2004. In this month it was reported that medical regulators have advised patients to stop utilizing the painkiller diclofenac. The cogent researchers have also reported that COX-2 was found in the blood vessels which prevent the formation of clots. As a result any drug which inhibits the enzyme was thought to higher risk of clotting.
Eventually new research predicts future development of COX-2 inhibitors that carry reduced risk of stroke or heart attack is quite possible for benefit of global patients. It also helps to ameliorate therapy for many millions of patients globally. The global researchers have utilized most sophisticated techniques to analyze the locations of COX-2 within the body.